Terms: = Germ cell tumor AND STAT5B, STAT5, 6777, ENSG00000173757, P51692 AND Treatment
36 results:
1. Myb Repression Mediates stat5b-knockdown-induced Apoptosis and Inhibits Proliferation of Glioblastoma Stem cells.
Moyama C; Fujita M; Okamoto H; Ii H; Nakata S
Cancer Genomics Proteomics; 2023; 20(2):195-202. PubMed ID: 36870690
[TBL] [Abstract] [Full Text] [Related]
2. Phase II clinical and immune correlate study of adjuvant nivolumab plus ipilimumab for high-risk resected melanoma.
Khushalani NI; Vassallo M; Goldberg JD; Eroglu Z; Kim Y; Cao B; Ferguson R; Monson KR; Kirchhoff T; Amato CM; Burke P; Strange A; Monk E; Gibney GT; Kudchadkar R; Markowitz J; Brohl AS; Pavlick A; Richards A; Woods DM; Weber J
J Immunother Cancer; 2022 Nov; 10(11):. PubMed ID: 36450385
[TBL] [Abstract] [Full Text] [Related]
3. stat5b is a marker of poor prognosis, rather than a therapeutic target in glioblastomas.
Dubois N; Berendsen S; Tan K; Schoysmans L; Spliet W; Seute T; Bours V; Robe PA
Int J Oncol; 2022 Oct; 61(4):. PubMed ID: 36069226
[TBL] [Abstract] [Full Text] [Related]
4. Targeting the extra domain A of fibronectin for cancer therapy with CAR-T cells.
Martín-Otal C; Lasarte-Cia A; Serrano D; Casares N; Conde E; Navarro F; Sánchez-Moreno I; Gorraiz M; Sarrión P; Calvo A; De Andrea CE; Echeveste J; Vilas A; Rodriguez-Madoz JR; San Miguel J; Prosper F; Hervas-Stubbs S; Lasarte JJ; Lozano T
J Immunother Cancer; 2022 Aug; 10(8):. PubMed ID: 35918123
[TBL] [Abstract] [Full Text] [Related]
5. tumor-related molecular determinants of neurocognitive deficits in patients with diffuse glioma.
van Kessel E; Berendsen S; Baumfalk AE; Venugopal H; Krijnen EA; Spliet WGM; van Hecke W; Giuliani F; Seute T; van Zandvoort MJE; Snijders TJ; Robe PA
Neuro Oncol; 2022 Oct; 24(10):1660-1670. PubMed ID: 35148403
[TBL] [Abstract] [Full Text] [Related]
6. Ivermectin accelerates autophagic death of glioma cells by inhibiting glycolysis through blocking GLUT4 mediated JAK/STAT signaling pathway activation.
Feng Y; Wang J; Cai B; Bai X; Zhu Y
Environ Toxicol; 2022 Apr; 37(4):754-764. PubMed ID: 34904774
[TBL] [Abstract] [Full Text] [Related]
7. MiR-920 and LSP1 co-regulate the growth and migration of glioblastoma cells by modulation of JAK2/stat5 pathway.
Cong P; Hou HY; Wei W; Zhou Y; Yu XM
J Bioenerg Biomembr; 2020 Oct; 52(5):311-320. PubMed ID: 32770294
[TBL] [Abstract] [Full Text] [Related]
8. Identification of Potential Biomarkers for Anti-PD-1 Therapy in Melanoma by Weighted Correlation Network Analysis.
Wang X; Chai Z; Li Y; Long F; Hao Y; Pan G; Liu M; Li B
Genes (Basel); 2020 Apr; 11(4):. PubMed ID: 32316408
[TBL] [Abstract] [Full Text] [Related]
9. A self-designed CpG ODN enhanced the anti-melanoma effect of pimozide.
Jia H; Guo J; Wang P; Sun K; Chen J; Ren W; Wei T; Yang Y; Li J; Liu X; Li R; Zhong J; Wang M; Tian Z; Feng Z; Zhao T
Int Immunopharmacol; 2020 Jun; 83():106397. PubMed ID: 32220805
[TBL] [Abstract] [Full Text] [Related]
10. Therapeutic melanoma vaccine with cancer stem cell phenotype represses exhaustion and maintains antigen-specific T cell stemness by up-regulating BCL6.
Czerwinska P; Rucinski M; Wlodarczyk N; Jaworska A; Grzadzielewska I; Gryska K; Galus L; Mackiewicz J; Mackiewicz A
Oncoimmunology; 2020; 9(1):1710063. PubMed ID: 32002306
[TBL] [Abstract] [Full Text] [Related]
11. Final Analysis of DeCOG-SLT Trial: No Survival Benefit for Complete Lymph Node Dissection in Patients With Melanoma With Positive Sentinel Node.
Leiter U; Stadler R; Mauch C; Hohenberger W; Brockmeyer NH; Berking C; Sunderkötter C; Kaatz M; Schatton K; Lehmann P; Vogt T; Ulrich J; Herbst R; Gehring W; Simon JC; Keim U; Verver D; Martus P; Garbe C;
J Clin Oncol; 2019 Nov; 37(32):3000-3008. PubMed ID: 31557067
[TBL] [Abstract] [Full Text] [Related]
12. The enhanced antitumour response of pimozide combined with the IDO inhibitor L‑MT in melanoma.
Jia H; Ren W; Feng Y; Wei T; Guo M; Guo J; Zhao J; Song X; Wang M; Zhao T; Wang H; Feng Z; Tian Z
Int J Oncol; 2018 Sep; 53(3):949-960. PubMed ID: 30015838
[TBL] [Abstract] [Full Text] [Related]
13. Targeting the cellular schizophrenia. Likely employment of the antipsychotic agent pimozide in treatment of refractory cancers and glioblastoma.
Elmaci I; Altinoz MA
Crit Rev Oncol Hematol; 2018 Aug; 128():96-109. PubMed ID: 29958636
[TBL] [Abstract] [Full Text] [Related]
14. Clinical features and the molecular biomarkers of olfactory neuroblastoma.
Peng X; Liu Y; Peng X; Wang Z; Zhang Z; Qiu Y; Jin M; Wang R; Kong D
Pathol Res Pract; 2018 Aug; 214(8):1123-1129. PubMed ID: 29921494
[TBL] [Abstract] [Full Text] [Related]
15. EGFRvIII-stat5 Signaling Enhances Glioblastoma cell Migration and Survival.
Roos A; Dhruv HD; Peng S; Inge LJ; Tuncali S; Pineda M; Millard N; Mayo Z; Eschbacher JM; Loftus JC; Winkles JA; Tran NL
Mol Cancer Res; 2018 Jul; 16(7):1185-1195. PubMed ID: 29724813
[TBL] [Abstract] [Full Text] [Related]
16. Pivotal role of NAMPT in the switch of melanoma cells toward an invasive and drug-resistant phenotype.
Ohanna M; Cerezo M; Nottet N; Bille K; Didier R; Beranger G; Mograbi B; Rocchi S; Yvan-Charvet L; Ballotti R; Bertolotto C
Genes Dev; 2018 Mar; 32(5-6):448-461. PubMed ID: 29567766
[TBL] [Abstract] [Full Text] [Related]
17. DKK2 imparts tumor immunity evasion through β-catenin-independent suppression of cytotoxic immune-cell activation.
Xiao Q; Wu J; Wang WJ; Chen S; Zheng Y; Yu X; Meeth K; Sahraei M; Bothwell ALM; Chen L; Bosenberg M; Chen J; Sexl V; Sun L; Li L; Tang W; Wu D
Nat Med; 2018 Mar; 24(3):262-270. PubMed ID: 29431745
[TBL] [Abstract] [Full Text] [Related]
18. Identification of a novel fusion gene HMGA2-EGFR in glioblastoma.
Komuro A; Raja E; Iwata C; Soda M; Isogaya K; Yuki K; Ino Y; Morikawa M; Todo T; Aburatani H; Suzuki H; Ranjit M; Natsume A; Mukasa A; Saito N; Okada H; Mano H; Miyazono K; Koinuma D
Int J Cancer; 2018 Apr; 142(8):1627-1639. PubMed ID: 29193056
[TBL] [Abstract] [Full Text] [Related]
19. Argon mediates protection by interleukin-8 suppression via a TLR2/TLR4/STAT3/NF-κB pathway in a model of apoptosis in neuroblastoma cells in vitro and following ischemia-reperfusion injury in rat retina in vivo.
Ulbrich F; Lerach T; Biermann J; Kaufmann KB; Lagreze WA; Buerkle H; Loop T; Goebel U
J Neurochem; 2016 Sep; 138(6):859-73. PubMed ID: 27167824
[TBL] [Abstract] [Full Text] [Related]
20. Combination of an anti-EGFRvIII antibody CH12 with Rapamycin synergistically inhibits the growth of EGFRvIII+PTEN-glioblastoma in vivo.
Xu W; Bi Y; Kong J; Zhang J; Wang B; Li K; Tian M; Pan X; Shi B; Gu J; Jiang H; Kong X; Li Z
Oncotarget; 2016 Apr; 7(17):24752-65. PubMed ID: 27029073
[TBL] [Abstract] [Full Text] [Related]
[Next]
